Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2026
상품코드:1942563
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
만성폐쇄성폐질환(COPD) 및 천식 치료 기기 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 475억 6,000만 달러에서 2026년에는 503억 달러로, CAGR 5.8%로 확대할 전망입니다. 지난 수년간의 성장은 천식 및 COPD 유병률 증가, 대기오염 및 흡연율 증가, 흡입 요법 사용 확대, 호흡기 치료 서비스 확대, 만성 호흡기 질환의 진단 정확도 향상에 기인하는 것으로 추정됩니다.
만성폐쇄성폐질환(COPD) 및 천식 치료 기기 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 628억 3,000만 달러에 달하며, CAGR은 5.7%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 호흡기 질환 위험이 높은 고령화 인구 증가, 가정용 호흡기 기기 수요 증가, 조기 호흡기 질환 관리에 대한 인식 개선, 만성질환 관리 프로그램 확대, 신흥 시장에서의 호흡기 치료 접근성 확대 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 재택용 호흡기 케어 기기 도입 증가, 휴대가 간편하고 사용하기 쉬운 흡입기에 대한 수요 증가, 장기 질환 관리 솔루션에 대한 관심 증가, 소아 및 노년층에서 기기 사용 확대, 치료 순응도 및 증상 관리에 대한 강조 강화 등이 있습니다.
호흡기 질환의 유병률 증가는 향후 만성폐쇄성폐질환(COPD) 및 천식 치료 기기 시장의 성장을 가속할 것으로 예측됩니다. 호흡기 질환에는 천식, 만성폐쇄성폐질환, 폐렴, 폐암 등 폐와 호흡기에 영향을 미치고 호흡기능과 전신 호흡기능에 악영향을 미치는 많은 병태가 포함됩니다. 호흡기 질환 증가 추세는 대기오염 증가, 알레르겐과 병원균에 영향을 미치는 기후 패턴의 변화, 흡연과 같은 호흡기 건강을 해치는 생활습관에 기인합니다. COPD 및 천식 치료 장비는 호흡기 질환의 종합적인 관리와 치료에 중요한 역할을 하며, 환자의 호흡기 건강 개선과 전반적인 건강 증진에 도움을 줍니다. 예를 들어 미국 정부기관인 국립생물공학정보센터(NCBI)에 따르면 2023년 12월 기준 COPD 환자 수는 2050년까지 1억 1,200만 명 증가하여 약 5억 9,200만 명에 달할 것으로 예상되며, 이는 전체 인구의 약 9.5%에 해당하는 수치입니다. 이러한 호흡기 질환 증가 추세는 COPD 및 천식 치료 기기 시장의 성장을 가속하고 있습니다.
만성폐쇄성폐질환 및 천식 치료 기기 시장에서 활동하는 주요 기업은 복약 순응도 강화, 실시간 증상 모니터링, 개인 맞춤형 호흡기 질환 관리 지원을 위한 스마트 센서 탑재 흡입기 기술 등 혁신적인 솔루션 개발에 주력하고 있습니다. 스마트 흡입기 기술은 내장 센서와 디지털 연결 기능을 통합하여 흡입 데이터를 수집하고 환자의 사용 패턴을 추적하여 환자와 의료진 모두에게 실행 가능한 인사이트을 제공합니다. 예를 들어 2023년 7월 영국에 본사를 둔 제약회사 테바UK(Teva UK)는 GoResp Digihaler(GoResp Digihaler)를 발표했습니다. 이 제품은 흡입 매개변수를 기록하고, 실시간 피드백을 제공하며, 데이터에 기반한 환자 참여를 통해 질병 관리를 개선할 수 있도록 설계된 디지털 연결형 흡입기입니다. 이 장치는 원격 모니터링이 가능하여 임상의가 환자의 복약 순응도 패턴을 보다 명확하게 파악할 수 있게 함으로써 만성 호흡기 질환 환자의 장기적인 질병 관리를 강화하여 치료 결과를 개선하는 데 기여합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Devices for chronic obstructive pulmonary disease (COPD) and asthma are medical tools designed to manage and treat breathing and respiratory issues. These devices assist patients in breathing more efficiently, controlling symptoms, and enhancing their overall quality of life.
Key types of these devices include metered dose inhalers, dry powder inhalers, soft mist inhalers, jet nebulizers, ultrasonic nebulizers, and others. Metered Dose Inhalers are portable devices that administer medication in a precise spray or mist, commonly used for conditions such as COPD and asthma by delivering the medication directly into the lungs. They are small and easy to carry, making them suitable for everyday use. These devices are utilized in various settings such as hospitals, clinics, home care, and research facilities, and cater to different age groups including pediatric, adult, and geriatric patients.
Tariffs are impacting the COPD and asthma devices market by increasing costs for imported components such as plastics, electronic parts, and precision valves used in inhalers and nebulizers. These higher costs have impacted pricing for metered dose inhalers and nebulizer systems, particularly in asia-pacific and north america where global supply chains are heavily integrated. Increased tariffs have placed pressure on manufacturers and distributors supplying hospitals and home care settings. However, tariffs have also encouraged local manufacturing, alternative sourcing strategies, and cost-efficient device designs, supporting long-term supply chain resilience.
The chronic obstructive pulmonary disease (copd) and asthma devices market research report is one of a series of new reports from The Business Research Company that provides chronic obstructive pulmonary disease (copd) and asthma devices market statistics, including chronic obstructive pulmonary disease (copd) and asthma devices industry global market size, regional shares, competitors with a chronic obstructive pulmonary disease (copd) and asthma devices market share, detailed chronic obstructive pulmonary disease (copd) and asthma devices market segments, market trends and opportunities, and any further data you may need to thrive in the chronic obstructive pulmonary disease (copd) and asthma devices industry. This chronic obstructive pulmonary disease (copd) and asthma devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The chronic obstructive pulmonary disease (copd) and asthma devices market size has grown strongly in recent years. It will grow from $47.56 billion in 2025 to $50.3 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising prevalence of asthma and COPD, increasing air pollution and smoking rates, growing use of inhalation therapy, expansion of respiratory care services, improved diagnosis of chronic respiratory diseases.
The chronic obstructive pulmonary disease (copd) and asthma devices market size is expected to see strong growth in the next few years. It will grow to $62.83 billion in 2030 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to aging population with higher respiratory risk, rising demand for home care respiratory devices, increasing awareness of early respiratory disease management, expansion of chronic disease management programs, growing access to respiratory care in emerging markets. Major trends in the forecast period include rising adoption of home-based respiratory care devices, increasing demand for portable and user-friendly inhalation devices, growing focus on long-term disease management solutions, expansion of device usage across pediatric and geriatric populations, increasing emphasis on treatment adherence and symptom control.
The growing prevalence of respiratory diseases is expected to propel the growth of the chronic obstructive pulmonary disease (COPD) and asthma devices market going forward. Respiratory diseases encompass many conditions affecting the lungs and respiratory systems, such as asthma, chronic obstructive pulmonary disease, pneumonia, and lung cancer, impacting breathing and overall respiratory function. The growing prevalence of respiratory diseases is due to increasing air pollution levels, changing climate patterns affecting allergens and pathogens, and lifestyle habits such as smoking that compromise respiratory health. COPD and asthma devices play a crucial role in the comprehensive management and treatment of respiratory diseases, supporting patients to achieve better respiratory health and enhance their overall well-being. For example, in December 2023, according to the National Center for Biotechnology Information, a US-based government agency, the number of COPD cases was projected to increase by 112 million to reach approximately 592 million by 2050, accounting for about 9.5% of the eligible population. This rising prevalence of respiratory diseases is fueling growth in the COPD and asthma devices market.
Major companies operating in the chronic obstructive pulmonary disease and asthma devices market are concentrating on the development of innovative solutions such as smart, sensor-enabled inhaler technologies to improve medication adherence, enable real-time symptom monitoring, and support personalized respiratory disease management. Smart inhaler technologies integrate embedded sensors and digital connectivity to capture inhalation data, track patient usage patterns, and provide actionable insights to both patients and healthcare professionals. For example, in July 2023, Teva UK Ltd., a UK-based pharmaceutical company, launched GoResp Digihaler, a digitally connected inhaler designed to record inhalation parameters, deliver real-time feedback, and support improved disease control through data-driven patient engagement. The device contributes to better treatment outcomes by enabling remote monitoring, offering clinicians enhanced visibility into patient adherence patterns, and strengthening long-term disease management for individuals with chronic respiratory conditions.
In January 2025, Molex LLC, a US-based global electronics and connectivity solutions company, completed the acquisition of Vectura Group for an undisclosed amount. With this acquisition, Molex seeks to enhance its healthcare and medical device capabilities by incorporating Vectura's advanced inhalation and drug-delivery technologies, thereby expanding its portfolio of connected, patient-centric respiratory solutions. Vectura Group is a UK-based pharmaceutical and medical device company that specializes in inhaled drug-delivery systems for COPD, asthma, and other respiratory conditions.
Major companies operating in the chronic obstructive pulmonary disease (copd) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc., Aerogen Ltd
North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2025. The regions covered in the chronic obstructive pulmonary disease (copd) and asthma devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the chronic obstructive pulmonary disease (copd) and asthma devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The chronic obstructive pulmonary disease (COPD) and asthma devices market consists of sales of spacer devices, peak flow meters, oxygen therapy equipment, pulse oximeters, and airway clearance devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses chronic obstructive pulmonary disease (copd) and asthma devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chronic obstructive pulmonary disease (copd) and asthma devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic obstructive pulmonary disease (copd) and asthma devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Metered Dose Inhalers; Drug Powder Inhalers; Soft Mist Inhalers; Jet Nebulizers; Ultrasonic Nebulizers; Other Types
2) By Indication: Asthma; Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals; Clinics; Home Care Settings; Research Institutions; Other Applications
4) By End User: Pediatric; Adult; Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI; Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI); Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers; Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers; Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers; Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories; Spacer Devices
Companies Mentioned: AstraZeneca Plc; Novartis AG; GlaxoSmithKline Plc; Boehringer Ingelheim; Royal Philips NV; Teva Pharmaceuticals Industries Ltd.; Omron Corporation; Smiths Medical Inc.; Cipla Ltd.; Chiesi Farmaceutici SpA; Sunovion Pharmaceuticals Inc.; Drive DeVilbiss Healthcare; Pari Respiratory Equipment Inc.; Allied Healthcare Products Inc.; Clement Clarke International Ltd.; Cohero Health Inc.; Pneuma Respiratory Inc.; Mundipharma International Ltd.; 3M Health Care; Vyaire Medical Inc.; Aerogen Ltd
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
4.2.1 Rising Adoption Of Home-Based Respiratory Care Devices
4.2.2 Increasing Demand For Portable And User-Friendly Inhalation Devices
4.2.3 Growing Focus On Long-Term Disease Management Solutions
4.2.4 Expansion Of Device Usage Across Pediatric And Geriatric Populations
4.2.5 Increasing Emphasis On Treatment Adherence And Symptom Control
5. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Home Care Settings
5.4 Pediatric Patients
5.5 Geriatric Patients
6. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Size, Comparisons And Growth Rate Analysis
7.3. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Metered Dose Inhalers, Drug Powder Inhalers, Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Other Types
9.2. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Asthma, Chronic Obstructive Pulmonary Disease
9.3. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Home Care Settings, Research Institutions, Other Applications
9.4. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pediatric, Adult, Geriatric
9.5. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Conventional MDI, Breath-Actuated MDI
9.6. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Drug Powder Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Dry Powder Inhalers (DPI), Multi-Dose DPI
9.7. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Soft Mist Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Respimat Soft Mist Inhalers, Other Soft Mist Devices
9.8. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Jet Nebulizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pneumatic Nebulizers, Venturi-Type Nebulizers
9.9. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Ultrasonic Nebulizers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.10. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Nebulizer Accessories, Spacer Devices
10. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Regional And Country Analysis
10.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
12.1. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
13.1. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
14.1. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
15.1. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
16.1. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
17.1. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
19.1. South East Asia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
20.1. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
21.1. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22.1. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
23.1. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25.1. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
26.1. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
27.1. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
28.1. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
29.1. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
31.1. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
32.1. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
33.1. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
34.1. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Segmentation By Indication, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Regulatory and Investment Landscape
36. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Landscape And Company Profiles
36.1. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Company Profiles
36.3.1. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
36.3.3. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Royal Philips NV Overview, Products and Services, Strategy and Financial Analysis
37. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Other Major And Innovative Companies
Teva Pharmaceuticals Industries Ltd., Omron Corporation, Smiths Medical Inc., Cipla Ltd., Chiesi Farmaceutici SpA, Sunovion Pharmaceuticals Inc., Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd., 3M Health Care, Vyaire Medical Inc.
38. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market
40. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market High Potential Countries, Segments and Strategies
40.1 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2030 - Countries Offering Most New Opportunities
40.2 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2030 - Segments Offering Most New Opportunities
40.3 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2030 - Growth Strategies
